AU2015279428B2 - Methods for the preparation of 1,3-benzodioxole heterocyclic compounds - Google Patents

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds Download PDF

Info

Publication number
AU2015279428B2
AU2015279428B2 AU2015279428A AU2015279428A AU2015279428B2 AU 2015279428 B2 AU2015279428 B2 AU 2015279428B2 AU 2015279428 A AU2015279428 A AU 2015279428A AU 2015279428 A AU2015279428 A AU 2015279428A AU 2015279428 B2 AU2015279428 B2 AU 2015279428B2
Authority
AU
Australia
Prior art keywords
formula
compound
defined above
chloro
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2015279428A
Other languages
English (en)
Other versions
AU2015279428A1 (en
Inventor
Andre Faldt
Bjorn Metzler
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharma AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma AS filed Critical Leo Pharma AS
Publication of AU2015279428A1 publication Critical patent/AU2015279428A1/en
Application granted granted Critical
Publication of AU2015279428B2 publication Critical patent/AU2015279428B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
AU2015279428A 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds Ceased AU2015279428B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP14173397 2014-06-23
EP14173397.2 2014-06-23
PCT/EP2015/063942 WO2015197534A2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Publications (2)

Publication Number Publication Date
AU2015279428A1 AU2015279428A1 (en) 2017-01-05
AU2015279428B2 true AU2015279428B2 (en) 2018-02-15

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2015279428A Ceased AU2015279428B2 (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Country Status (18)

Country Link
US (1) US9908894B2 (OSRAM)
EP (1) EP3157930B1 (OSRAM)
JP (1) JP6785666B2 (OSRAM)
KR (1) KR20170016894A (OSRAM)
CN (1) CN106459081B (OSRAM)
AU (1) AU2015279428B2 (OSRAM)
BR (1) BR112016029510A2 (OSRAM)
CA (1) CA2953284A1 (OSRAM)
DK (1) DK3157930T3 (OSRAM)
ES (1) ES2702451T3 (OSRAM)
IL (1) IL249336A0 (OSRAM)
MX (1) MX2016016378A (OSRAM)
PL (1) PL3157930T3 (OSRAM)
PT (1) PT3157930T (OSRAM)
RU (1) RU2697251C2 (OSRAM)
TW (1) TW201613934A (OSRAM)
WO (1) WO2015197534A2 (OSRAM)
ZA (1) ZA201608442B (OSRAM)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3007432A1 (en) * 2015-12-18 2017-06-22 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
WO2018234299A1 (en) * 2017-06-20 2018-12-27 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
CN111727191B (zh) 2017-12-15 2024-01-05 联合疗法公司 取代的氮杂环丁烷二氢噻吩并吡啶类化合物及其作为磷酸二酯酶抑制剂的用途
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
IL284815B2 (en) 2019-01-15 2025-10-01 Union Therapeutics As Modified-release tablet formulations containing phosphodiesterase inhibitors
AU2022245186A1 (en) 2021-03-22 2023-10-05 UNION therapeutics A/S Treatment of hidradenitis suppurativa with orismilast
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008104175A2 (en) * 2007-02-28 2008-09-04 Leo Pharma A/S Novel phosphodiesterase inhibitors
WO2011160632A1 (en) * 2010-06-24 2011-12-29 Leo Pharma A/S Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
AU705690B2 (en) * 1995-05-19 1999-05-27 Kyowa Hakko Kogyo Co. Ltd. Oxygen-containing heterocyclic compounds
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
US20050245750A1 (en) * 2002-07-03 2005-11-03 Kyowa Hakko Kogyo Co., Ltd. Process for preparing 1,3-benzodioxole-2-spirocycloalkane derivative
CN101490004B (zh) * 2006-07-14 2012-01-11 奇斯药制品公司 作为磷酸二酯酶抑制剂的1-苯基-2-吡啶基烯基醇的衍生物
KR101507717B1 (ko) 2006-12-22 2015-04-08 레오 파마 에이/에스 Pde4 억제제로서 유용한 치환된 아세토페논
UA98639C2 (en) * 2007-02-28 2012-06-11 Лео Фарма А/С Phosphodiesterase inhibitors
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
CA3007432A1 (en) * 2015-12-18 2017-06-22 Leo Pharma A/S Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008104175A2 (en) * 2007-02-28 2008-09-04 Leo Pharma A/S Novel phosphodiesterase inhibitors
WO2011160632A1 (en) * 2010-06-24 2011-12-29 Leo Pharma A/S Benzodioxole or benzodioxepine heterocyclic compounds phosphodiesterase inhibitors

Also Published As

Publication number Publication date
CA2953284A1 (en) 2015-12-30
AU2015279428A1 (en) 2017-01-05
BR112016029510A2 (pt) 2017-08-22
JP6785666B2 (ja) 2020-11-18
ES2702451T3 (es) 2019-03-01
TW201613934A (en) 2016-04-16
KR20170016894A (ko) 2017-02-14
WO2015197534A3 (en) 2016-03-17
CN106459081B (zh) 2019-09-10
PL3157930T3 (pl) 2019-04-30
EP3157930A2 (en) 2017-04-26
MX2016016378A (es) 2017-10-16
US9908894B2 (en) 2018-03-06
CN106459081A (zh) 2017-02-22
US20170137438A1 (en) 2017-05-18
RU2017101808A3 (OSRAM) 2019-01-22
WO2015197534A2 (en) 2015-12-30
IL249336A0 (en) 2017-02-28
JP2017520547A (ja) 2017-07-27
DK3157930T3 (en) 2019-01-21
RU2697251C2 (ru) 2019-08-13
PT3157930T (pt) 2018-12-24
EP3157930B1 (en) 2018-10-17
ZA201608442B (en) 2018-05-30
RU2017101808A (ru) 2018-07-27

Similar Documents

Publication Publication Date Title
AU2015279428B2 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
RU2430092C2 (ru) Способ получения телмисартана
JP7549635B2 (ja) 1,3-ベンゾジオキソール複素環式化合物の調製方法
JP6934872B2 (ja) 1,3−ベンゾジオキソール複素環化合物の製造方法
CN102351778A (zh) 一种盐酸阿比朵尔的制备方法
HK1231056A1 (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
HK40029630B (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
HK40029630A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
HK1258964B (zh) 用於制备1,3-苯并间二氧杂环戊烯杂环化合物的方法

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired